Article Details
Retrieved on: 2024-02-25 23:20:11
Tags for this article:
Click the tags to see associated articles and topics
Summary
The Durham-based biotech company Avicenna Biosciences raised $6 million for drug development targeted at neurodegenerative diseases, using advanced technologies like machine learning, as reported by sources including Crunchbase.
Article found on: businessnc.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here